Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
about
Hypometabolism as a therapeutic target in Alzheimer's diseaseNovel therapeutics for Alzheimer's disease: an updateThiamine triphosphate synthesis in rat brain occurs in mitochondria and is coupled to the respiratory chainShift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventionsDefects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's diseaseStem cell-based models and therapies for neurodegenerative diseasesCoenzyme Q protects Caenorhabditis elegans GABA neurons from calcium-dependent degeneration.The Arabidopsis RETARDED ROOT GROWTH gene encodes a mitochondria-localized protein that is required for cell division in the root meristem.Oxidatively modified, mitochondria-relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment.Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.Estrogen: a master regulator of bioenergetic systems in the brain and bodyOxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies.Age-related changes in mitochondrial respiration and oxidative damage in the cerebral cortex of the Fischer 344 rat.Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responsesDecrease in age-related tau hyperphosphorylation and cognitive improvement following vitamin D supplementation are associated with modulation of brain energy metabolism and redox state.Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis.Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases.Age-related mitochondrial changes after traumatic brain injuryA TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's diseaseTargeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.Global cPILOT analysis of the APP/PS-1 mouse liver proteome.Ketone bodies as a therapeutic for Alzheimer's disease.Is brain amyloid production a cause or a result of dementia of the Alzheimer's type?3,4,5-tri-O-caffeoylquinic acid inhibits amyloid β-mediated cellular toxicity on SH-SY5Y cells through the upregulation of PGAM1 and G3PDH.Alterations in energy metabolism, neuroprotection and visual signal transduction in the retina of Parkinsonian, MPTP-treated monkeysThe role of telomerase protein TERT in Alzheimer's disease and in tau-related pathology in vitro.Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's diseaseA glycine zipper motif mediates the formation of toxic β-amyloid oligomers in vitro and in vivo.Behavioral improvement after chronic administration of coenzyme Q10 in P301S transgenic mice.The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brainAlterations in Lipid Levels of Mitochondrial Membranes Induced by Amyloid-β: A Protective Role of Melatonin.Ginsenoside Rg1 attenuates oligomeric Aβ(1-42)-induced mitochondrial dysfunction.Aerobic Glycolysis in the Frontal Cortex Correlates with Memory Performance in Wild-Type Mice But Not the APP/PS1 Mouse Model of Cerebral Amyloidosis.Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy EraThe heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's diseaseApolipoprotein e sets the stage: response to injury triggers neuropathology.Oxidative modification of lipoic acid by HNE in Alzheimer disease brain.Protein expression overlap: more important than which proteins change in expression?Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disordersMitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
P2860
Q21262020-D89CB5B7-014F-46C8-A9CB-9993BA57B9FDQ24620383-6CA89F2F-7374-4195-91A6-92C51DAA517BQ24648251-3BEC0022-7E1E-4587-84C2-A998555435BCQ26830740-669B7F07-39B3-43AB-BFB5-2049FB0937C1Q27307877-4B40C39B-DFD9-4E45-B9DE-8F12190EA949Q30451005-F82E94B1-CF39-4326-BBFC-2C0CC764F761Q30496117-E69F976A-C28B-431B-9257-986B9E43028BQ33352303-2BF5E1C9-F87B-49BA-A437-2947B09F66AFQ33506441-0E3E0EB6-7201-4CCB-8A19-F26F94D068CDQ33614523-62ED67A8-2B0A-4D22-9049-F5752E65298BQ33623924-F9AE6ACB-6C7F-4BB9-91D8-6E7A1CEC1EF2Q33625254-287C346F-1312-467B-8D9F-E0977FA775E8Q33709605-8AC6EAEB-2438-455E-947C-715A5C6FE21EQ33778336-5EFD03B9-FB31-4D99-90D8-D91DE4721FA6Q33919070-C58591C7-E72B-4923-9DC3-04D14764C25AQ33975871-4B0A8346-6046-4577-83CE-1CB4242899A6Q34092740-5B8A674E-86AF-46D6-A46E-52C90118D626Q34147870-CAA46881-3034-49A8-B3DC-6076E63A7F5CQ34159318-B6F433D8-C7CC-45F9-86D5-4404881BE97DQ34407220-9E6E8277-09C5-4C9F-817D-B96A374BF802Q34459615-1CDBE283-EB64-4E6B-8FC1-AE4EB90A9AAAQ34795761-B39BD1FE-CD3A-4362-90FF-B7EB2CD987D1Q34814013-491D531C-13DE-4B8C-A862-4E0F6CF00D1DQ34827756-FEF7D706-FF40-48BF-BA00-462BDAFE8611Q34990005-103AB803-5455-4F7F-BFEE-3B8FA8E7BCCEQ35020283-4D77816E-25E3-4197-B448-707E128B7031Q35035669-DF7EB481-2F87-4FB3-BA11-302BB62572D4Q35227639-A585243A-9E46-4BFF-AAD9-AAAF50F4DA57Q35756089-0CBA20E8-0C71-42B3-9F46-166889FBC448Q35845628-1B5F4D81-AAF7-451B-92AA-A54834F2A543Q35993891-97416B2D-5173-4F87-BCC3-6B952EB80184Q36054716-68D393E3-CF8A-466C-A2CE-28FA54960060Q36564543-5A494ED4-5E88-4822-A69F-E5883AB0CAA2Q36654580-F78F6803-D4DC-4839-BEF6-8165581010CFQ36660120-0D3F38C3-814C-40B8-BD47-26A6BF6BFF4BQ36963238-383331F8-518A-4553-B610-D538F58CF549Q37133480-F7AAD276-4AA0-4E13-AA5B-85838C304D15Q37157827-75F1BF76-65FA-45B8-8AE3-5D420BEEA0ADQ37199221-F1A8184A-D06B-4040-9986-F225DE6B7EA5Q37321251-CEB61D44-C8D1-4296-93ED-EA868E8912ED
P2860
Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
@en
type
label
Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
@en
prefLabel
Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
@en
P1433
P1476
Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease.
@en
P2093
Hani Atamna
William H Frey
P304
P356
10.1016/J.MITO.2007.06.001
P577
2007-06-13T00:00:00Z